This panel was asleep at the switch.

I think the FDA advisory committee was asleep at the switch, ... The question is, did they not get it, or did they get it and were not willing to stand their ground?

I expected the advisory panel to turn the drug down. When they didn't, I was really surprised. And so I now had a potential public health catastrophe in the waiting,

asleep at the switch.

We've been misled many times by observational studies like this,

Physicians ought to take this into account. These drugs are not very forgiving.